Clinical Trial Update: Nivolumab or Nivolumab Plus Cisplatin, in Combination With Radiotherapy in Patients With Cisplatin-ineligible or Eligible Locally Advanced Squamous Cell Head and Neck Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating nivolumab alone or with cisplatin plus radiotherapy in cisplatin-eligible or -ineligible locally advanced squamous cell carcinoma of th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Cell Carcinoma of the Head and Neck

Drugs mentioned

• nivolumab (nivolumab)
• nivolumab plus cisplatin

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Squamous Cell Carcinoma of the Head and Neck | Phase 3 | Status: COMPLETED | Results posted: 2021-08-09